GlobalData on MSN21h
Acadia submits MAA to EMA for Rett syndrome therapy
Acadia Pharmaceuticals has submitted a marketing authorisation application (MAA) to the European Medicines Agency (EMA) for ...
Pharmabiz1h
Acadia Pharma seeks European marketing approval for trofinetide for the treatment of Rett syndrome
Acadia Pharma seeks European marketing approval for trofinetide for the treatment of Rett syndrome: San Diego Thursday, January 16, 2025, 13:00 Hrs [IST] Acadia Pharmaceuticals In ...
ophthalmologytimes12d
European Medicines Agency to assess semaglutide for link to NAION
The Danish Medicines Agency requested the EMA's Pharmacovigilance Risk Assessment Committee review reports on the ...
FiercePharma9h
JPM25: Bayer gears up for 'must-win battles' as Xarelto loss of exclusivity in full swing, says pharma chief
These launches belong to what Oelrich called “must-win battles” at Bayer as Xarelto loss of exclusivity reaches “full swing” ...
pharmaphorum22d
European Medicines Agency reveals favoured cities for relocation
The European Medicines Agency has revealed a list of five cities that are preferred as its new location by staff after Brexit, following warnings of a public health disaster if EU leaders pick the ...
Acadia Pharmaceuticals Submits Marketing Authorization Application to the European Medicines Agency for Trofinetide for the Treatment of Rett Syndrome
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the company has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for trofinetide for the ...
CNBC on MSN23d
European markets close higher ahead of Christmas shutdown; Novo Nordisk resumes recovery
Novo Nordisk resumed its rally on Tuesday, rising to the top of the Stoxx 600 and adding 5.7% by the closing bell. Shares of ...
Acadia Pharma Submits MAA To EU Agency For Approval Of Trofinetide In Rett Syndrome
(RTTNews) - Acadia Pharmaceuticals Inc. (ACAD) Tuesday, announced the submission of a Marketing Authorization Application or MAA to the European Medicines Agency or EMA for its Trofinetide, targeting ...
Acadia Pharmaceuticals submits trofinetide MAA to EMA
Acadia Pharmaceuticals (ACAD) announced that the company has submitted a marketing authorization application to the European Medicines Agency ...
Hosted on MSN1d
Health Check: Biotech partnership eyes European market expansion for Rett syndrome drug
Neuren's partner Acadia Pharmaceuticals submits marketing authorisation application in Europe for trofinetide for treatment ...